CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 14 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,000 | -20.0% | 11,432 | +49.9% | 0.00% | – |
| Q4 2019 | $5,000 | -50.0% | 7,627 | -69.0% | 0.00% | – |
| Q3 2019 | $10,000 | – | 24,598 | +10881.2% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 224 | -79.1% | 0.00% | – |
| Q1 2019 | $1,000 | -80.0% | 1,074 | -86.7% | 0.00% | – |
| Q4 2018 | $5,000 | – | 8,093 | +4322.4% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 183 | -98.2% | 0.00% | – |
| Q2 2018 | $14,000 | +250.0% | 10,380 | +251.2% | 0.00% | – |
| Q1 2018 | $4,000 | +33.3% | 2,956 | +37.2% | 0.00% | – |
| Q4 2017 | $3,000 | -50.0% | 2,155 | -35.8% | 0.00% | – |
| Q3 2017 | $6,000 | +500.0% | 3,355 | +1763.9% | 0.00% | – |
| Q2 2017 | $1,000 | -87.5% | 180 | -91.8% | 0.00% | – |
| Q1 2017 | $8,000 | -27.3% | 2,186 | +4.2% | 0.00% | – |
| Q4 2016 | $11,000 | – | 2,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 21,000 | $28,000 | 0.00% |
| AJ WEALTH STRATEGIES, LLC | 12,677 | $17,000 | 0.00% |
| Virtu Financial LLC | 39,613 | $53,000 | 0.00% |
| BREWIN DOLPHIN LTD | 5,586 | $7,541 | 0.00% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 23 | $0 | 0.00% |
| UBS Group AG | 2,956 | $4,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 12,240 | $17,000 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $18,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $29,000 | 0.00% |